← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Lévocarnitine currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: lévocarnitine · LEVOCARNITINA · data refreshed 9 September 2026
As of 9 September 2026, 1 of the 9 tracked registers list current availability issues for Lévocarnitine, covering 2 affected product presentations. The longest-running open report was filed in Italy on 2023-02-01 and has now been open for about 43 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 2 stated-cause reports, followed by manufacturing problems with 1. The furthest expected-resolution date currently on file is 2026-10-18; the earliest is 2026-10-18. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇫🇷 France | Resolved Levocarnil 1 g/5 ml, solution injectable en ampoule | — | 2026-07-15 | Hépato-gastroentérologie | register ↗ |
| 🇮🇹 Italy | Shortage CARNITENE + 1 more productsWROM | 2023-02-01 | 2026-10-18 | Elevata richiesta Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Lévocarnitine in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | CARNITENE | Shortage | 2026-08-04 | 2026-10-18 | Elevata richiesta |
| 🇮🇹 IT | WROM | Shortage | 2023-02-01 | — | Problemi produttivi |
| 🇫🇷 FR | Levocarnil 1 g/5 ml, solution injectable en ampoule | Resolved | — | 2026-07-15 | Hépato-gastroentérologie |
Yes. As of 9 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-18 to 2026-10-18. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Lévocarnitine: ANSM (France), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Lévocarnitine — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/levocarnitine/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Lévocarnitine availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/levocarnitine/">Lévocarnitine shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>